Skip to content

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

Attila Szabo, Ede Frecska

Neural Regeneration Research 2016 DOI: 10.4103/1673-5374.179041 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Topics 5-MeO-DMT DMT
Keywords Neuroinflammation Pattern recognition receptor Immunology Microglia Chemokine Acquired immune system Innate immune system Neuroprotection Ccl18 Cell biology
Citations 42
Key points Argues that immune mechanisms, mainly microglial activity, may contribute to the etiology and symptomatology of neuropsychiatric conditions including schizophrenia, bipolar disorder, depression, and Alzheimer's disease, and that unwanted excess inflammation typically results from dysregulated innate immune responses.

Abstract

The inflammatory theory of many neuropsychiatric illnesses has become an emerging trend in modern medicine. Various immune mechanisms – mainly via the activity of microglia – may contribute to the etiology and symptomatology of diseases, such as schizophrenia, bipolar disorder, depression, or Alzheimer's disease (Deleidi et al. , 2015; Khandaker et al. , 2015). Unwanted and excess inflammation is most typically the result of dysregulated innate immune responses.

Comparable studies

Other theoretical and historical papers on DMT, most cited first.

Citations in the library

Explore topics